Clinical Trials of Monoclonal Antibodies to Prevent Covid-19 Enrolling
All trial participants will be followed for safety for seven months after efficacy assessment period ends. Two Phase 3, randomized,
Read moreAll trial participants will be followed for safety for seven months after efficacy assessment period ends. Two Phase 3, randomized,
Read moreThe Committee unanimously agreed that the outbreak still constitutes a public health emergency of international concern. The Emergency Committee on
Read moreThe Covid-19 Law Lab initiative gathers and shares legal documents from over 190 countries across the world to help states
Read moreThe Covid-19 Prevention Network (CoVPN) was formed by the National Institute of Allergy and Infectious Diseases (NIAID) at the US
Read moreBy RMN News Service President Donald Trump has claimed that his second-term victory in the presidential election will be a
Read moreBy RMN News Service Restrictions on movement imposed by governments across the world due to the Covid-19 pandemic have had
Read more